Three single-nucleotide polymorphisms of the angiotensinogen gene and susceptibility to hypertension: Single locus genotype vs. haplotype analysis

Physiological Genomics

Volumn 17, Issue , 2004, Pages 79-86

  Wu, Shyh Jong ^a   Chiang, Fu Tien ^b   Chen, Wei J ^c   Liu, Pi Hua ^c   Hsu, Kwan Lih ^b   Hwang, Juey Jen ^b   Lai, Ling Ping ^b   Lin, Jiunn Lee ^b   Tseng, Chuen Den ^b   Tseng, Yung Zu ^a,b  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Genetic polymorphism; Linkage disequilibrium; Recombination; Renin angiotensin system; Transcriptional activity

Indexed keywords

ANGIOTENSINOGEN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; GENE ACTIVITY; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC TRANSCRIPTION; GENOTYPE; HAPLOTYPE; HOMOZYGOTE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROMOTER REGION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SINGLE NUCLEOTIDE POLYMORPHISM; TAIWAN; COMPARATIVE STUDY; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; TUMOR CELL LINE;

ANGIOTENSINOGEN; CELL LINE, TUMOR; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HUMANS; HYPERTENSION; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS (GENETICS); TRANSCRIPTION, GENETIC;

EID: 3843067473     PISSN: 15312267     EISSN: None     Source Type: Journal    
DOI: 10.1152/physiolgenomics.00133.2003     Document Type: Article

References (47)

1. Abecasis GR, Noguchi E, Heinzmann A, Traherne JA, Bhattacharyya S, Leaves NI, Anderson GG, Zhang Y, Lench NJ, Carey A, Cardon LR, Moffatt MF, and Cookson WO. Extent and distribution of linkage disequilibrium in three genomic regions. Am J Hum Genet 68: 191-197, 2001.
2. Ardlie KG, Kruglyak L, and Seielstad M. Patterns of linkage disequilibrium in the human genome. Nat Rev Genet 3: 299-309, 2002.
3. Caulfield M, Lavender P, Farrall M, Munroe P, Lawson M, Turner P, and Clark AJ. Linkage of the angiotensinogen gene to essential hypertension. N Engl J Med 330: 1629-1633, 1994.
4. Chiang FT, Hsu KL, Tseng CD, Hsiao WH, Lo HM, Chern TH, and Tseng YZ. Molecular variant M235T of the angiotensinogen gene is associated with essential hypertension in Taiwanese. J Hypertens 15: 607-611, 1997.
5. Cvetkovic B, Keen HL, Zhang X, Davis D, Yang B, and Sigmund CD. Physiological significance of two common haplotypes of human angiotensinogen using gene targeting in the mouse. Physiol Genomics 11: 253-262, 2002.
6. Daly MJ, Rioux JD, Schaffner SF, Hudson TJ, and Lander ES. High-resolution haplotype structure in the human genome. Nat Genet 29: 229-232, 2001.
7. Danser AH, Derkx FH, Hense HW, Jeunemaitre X, Riegger GA, and Schunkert H. Angiotensinogen (M235T) and angiotensin-converting enzyme (1/D) polymorphisms in association with plasma renin and prorenin levels. J Hypertens 16: 1879-1883, 1998.
8. Fallin D, Cohen A, Essioux L, Chumakov I, Blumenfeld M, Cohen D, and Schork NJ. Genetic analysis of case/control data using estimated haplotype frequencies: application to APOE locus variation and Alzheimer's disease. Genome Res 11: 143-151, 2001.
9. Fallin D and Schork NJ. Accuracy of haplotype frequency estimation for biallelic loci, via the expectation-maximization algorithm for unphased diploid genotype data. Am J Hum Genet 67: 947-959, 2000.
10. Gabriel SB, Schaffner SF, Nguyen H, Moore JM, Roy J, Blumenstiel B, Higgins J, DeFelice M, Lochner A, Faggart M, Liu-Cordero SN, Rotimi C, Adeyemo A, Cooper R, Ward R, Lander ES, Daly MJ, and Altshuler D. The structure of haplotype blocks in the human genome. Science 296: 2225-2229, 2002.
11. Hill WG and Robertson A. Linkage disequilibrium in finite population. Theor Appl Genet 38: 226-231, 1968.
12. Inoue I, Nakajima T, Williams CS, Quackenbush J, Puryear R, Powers M, Cheng T, Ludwig EH, Sharma AM, Hata A, Jeunemaitre X, and Lalouel JM. A nucleotide substitution in the promoter of human angiotensinogen is associated with essential hypertension and affects basal transcription in vitro. J Clin Invest 99: 1786-1797, 1997.
13. Jain S, Tang X, Narayanan CS, Agarwal Y, Peterson SM, Brown CD, Ott J, and Kumar A. Angiotensinogen gene polymorphism at -217 affects basal promoter activity and is associated with hypertension in African-Americans. J Biol Chem 277: 36889-36896, 2002.
14. Jeffreys AJ, Kauppi L, and Neumann R. Intensely punctate meiotic recombination in the class II region of the major histocompatibility complex. Nat Genet 29: 217-222, 2001.
15. Jeunemaitre X, Inoue I, Williams C, Charru A, Tichet J, Powers M, Sharma AM, Gimenez-Roqueplo AP, Hata A, Corvol P, and Lalouel JM. Haplotypes of angiotensinogen in essential hypertension. Am J Hum Genet 60: 1448-1460, 1997.
16. Jeunemaitre X, Soubrier F, Kotelevtsev YV, Lifton RP, Williams CS, Charru A, Hunt SC, Hopkins PN, Williams RR, Lalouel JM, and et al. Molecular basis of human hypertension: role of angiotensinogen. Cell 71: 169-180, 1992.
17. Jorde LB. Linkage disequilibrium and the search for complex disease genes. Genome Res 10: 1435-1444, 2000.
18. Kato N, Sugiyama T, Morita H, Kurihara H, Yamori Y, and Yazaki Y. Angiotensinogen gene and essential hypertension in the Japanese: extensive association study and meta-analysis on six reported studies. J Hypertens 17: 757-763, 1999.
19. Kruglyak L. Prospects for whole-genome linkage disequilibrium mapping of common disease genes. Nat Genet 22: 139-144, 1999.
20. Krushkal J, Ferrell R, Mockrin SC, Turner ST, Sing CF, and Boerwinkle E. Genome-wide linkage analyses of systolic blood pressure using highly discordant siblings. Circulation 99: 1407-1410, 1999.
21. Lander ES and Schork NJ. Genetic dissection of complex traits. Science 265: 2037-2048, 1994.
22. Lange K. Mathematical and Statistical Methods for Genetic Analysis (2nd ed.). New York: Springer-Verlag, 2002.
23. Lewontin RC. The interaction of selection and linkage. 1. General considerations: hetrotic models. Genetics 49: 49-67, 1964.
24. Lifton RP, Gharavi AG, and Geller DS. Molecular mechanisms of human hypertension. Cell 104: 545-556, 2001.
25. Moreno MU, San Jose G, Orbe J, Paramo JA, Beloqui O, Diez J, and Zalba G. Preliminary characterisation of the promoter of the human p22(phox) gene: identification of a new polymorphism associated with hypertension. FEBS Lett 542: 27-31, 2003.
26. Nakabayashi H, Taketa K, Miyano K, Yamane T, and Sato J. Growth of human hepatoma cells lines with differentiated functions in chemically defined medium. Cancer Res 42: 3858-3863, 1982.
27. Nakajima T, Jorde LB, Ishigami T, Umemura S, Emi M, Lalouel JM, and Inoue I. Nucleotide diversity and haplotype structure of the human angiotensinogen gene in two populations. Am J Hum Genet 70: 108-123, 2002.
28. Niu T, Xu X, Rogus J, Zhou Y, Chen C, Yang J, Fang Z, Schmitz C, Zhao J, Rao VS, and Lindpaintner K. Angiotensinogen gene and hypertension in Chinese. J Clin Invest 101: 188-194, 1998.
29. Pritchard JK and Przeworski M. Linkage disequilibrium in humans: models and data. Am J Hum Genet 69: 1-14, 2001.
30. Rauramaa R, Kuhanen R, Lakka TA, Vaisanen SB, Halonen P, Alen M, Rankinen T, and Bouchard C. Physical exercise and blood pressure with reference to the angiotensinogen M235T polymorphism. Physiol Genomics 10: 71-77, 2002. First published June 11, 2002; 10.1152/ physiolgenomics.00050.2002.
31. Reich DE, Cargill M, Bolk S, Ireland J, Sabeti PC, Richter DJ, Lavery T, Kouyoumjian R, Farhadian SF, Ward R, and Lander ES. Linkage disequilibrium in the human genome. Nature 411: 199-204, 2001.
32. Rice T, Rankinen T, Province MA, Chagnon YC, Perusse L, Borecki IB, Bouchard C, and Rao DC. Genome-wide linkage analysis of systolic and diastolic blood pressure: the Quebec Family Study. Circulation 102: 1956-1963, 2000.
33. Risch NJ. Searching for genetic determinants in the new millennium. Nature 405: 847-856, 2000.
34. Romualdi C, Balding D, Nasidze IS, Risch G, Robichaux M, Sherry ST, Stoneking M, Batzer MA, and Barbujani G. Patterns of human diversity, within and among continents, inferred from biallelic DNA polymorphisms. Genome Res 12: 602-612, 2002.
35. Rotimi C, Morrison L, Cooper R, Oyejide C, Effiong E, Ladipo M, Osotemihen B, and Ward R. Angiotensinogen gene in human hypertension. Lack of an association of the 235T allele among African Americans. Hypertension 24: 591-594, 1994.
36. Sethi AA, Nordestgaard BG, Gronholdt ML, Steffensen R, Jensen G, and Tybjaerg-Hansen A. Angiotensinogen single nucleotide polymorphisms, elevated blood pressure, and risk of cardiovascular disease. Hypertension 41: 1202-1211, 2003.
37. Siffert W, Rosskopf D, Siffert G, Busch S, Moritz A, Erbel R, Sharma AM, Ritz E, Wichmann HE, Jakobs KH, and Horsthemke B. Association of a human G-protein beta3 subunit variant with hypertension. Nat Genet 18: 45-48, 1998.
38. Staessen JA, Kuznetsova T, Wang JG, Emelianov D, Vlietinck R, and Fagard R. M235T angiotensinogen gene polymorphism and cardiovascular renal risk. J Hypertens 17: 9-17, 1999.
39. Stephens JC, Schneider JA, Tanguay DA, Choi J, Acharya T, Stanley SE, Jiang R, Messer CJ, Chew A, Han JH, Duan J, Carr JL, Lee MS, Koshy B, Kumar AM, Zhang G, Newell WR, Windemuth A, Xu C, Kalbfleisch TS, Shaner SL, Arnold K, Schulz V, Drysdale CM, Nandabalan K, Judson RS, Ruano G, and Vovis GF. Haplotype variation and linkage disequilibrium in 313 human genes. Science 293: 489-493, 2001.
40. Templeton AR, Clark AG, Weiss KM, Nickerson DA, Boerwinkle E, and Sing CF. Recombinational and mutational hotspots within the human lipoprotein lipase gene. Am J Hum Genet 66: 69-83, 2000.
41. Terwilliger JD, Haghighi F, Hiekkalinna TS, and Goring HH. A bias-ed assessment of the use of SNPs in human complex traits. Curr Opin Genet Dev 12: 726-734, 2002.
42. Wall JD and Pritchard JK. Haplotype blocks and linkage disequilibrium in the human genome. Nat Rev Genet 4: 587-597, 2003.
43. Wu SJ, Chiang FT, Jiang JR, Hsu KL, Chern TH, and Tseng YZ. The G-217A variant of the angiotensinogen gene affects basal transcription and is associated with hypertension in a Taiwanese population. J Hypertens 21: 2061-2067, 2003.
44. Xu X, Rogus JJ, Terwedow HA, Yang J, Wang Z, Chen C, Niu T, Wang B, Xu H, Weiss S, Schork NJ, and Fang Z. An extreme-sib-pair genome scan for genes regulating blood pressure. Am J Hum Genet 64: 1694-1701, 1999.
45. Yanai K, Nibu Y, Murakami K, and Fukamizu A. A cis-acting DNA element located between TATA box and transcription initiation site is critical in response to regulatory sequences in human angiotensinogen gene. J Biol Chem 271: 15981-15986, 1996.
46. Zhu X, Chang YP, Yan D, Weder A, Cooper R, Luke A, Kan D, and Chakravarti A. Associations between hypertension and genes in the renin-angiotensin system. Hypertension 41: 1027-1034, 2003.
47. Zhu X, Yan D, Cooper RS, Luke A, Ikeda MA, Chang YP, Weder A, and Chakravarti A. Linkage disequilibrium and haplotype diversity in the genes of the renin-angiotensin system: findings from the family blood pressure program. Genome Res 13: 173-181, 2003.